USANA Health Sciences Inc (USNA)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 856,858 | 923,915 | 1,001,720 | 1,190,170 | 1,137,750 |
| Total current assets | US$ in thousands | 279,187 | 417,746 | 384,382 | 365,117 | 425,286 |
| Total current liabilities | US$ in thousands | 139,625 | 118,845 | 143,833 | 160,790 | 168,073 |
| Working capital turnover | 6.14 | 3.09 | 4.16 | 5.82 | 4.42 |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $856,858K ÷ ($279,187K – $139,625K)
= 6.14
Based on the data provided, the working capital turnover for USANA Health Sciences Inc has shown fluctuations over the past five years. The working capital turnover ratio indicates how efficiently the company is utilizing its working capital to generate sales revenue.
In 2020, the working capital turnover was 4.42, which means that for every dollar of working capital invested, the company generated $4.42 in revenue. This ratio increased to 5.82 in 2021, suggesting an improvement in the efficiency of working capital utilization.
However, there was a decline in the ratio in 2022 to 4.16, followed by a further decrease to 3.09 in 2023. These decreases indicate a potential inefficiency in managing working capital during these periods.
The ratio significantly improved in 2024, reaching 6.14, reflecting a more effective use of working capital to drive sales revenue.
Overall, while there have been fluctuations in the working capital turnover ratio for USANA Health Sciences Inc over the years, the company has demonstrated periods of efficiency in utilizing its working capital to generate revenue, with notable improvements in certain years.